Essapharma.com
Visit essapharma.com-
9 months ago
Last scanned
-
9 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Essapharma.com
Visit essapharma.com
About Website
Updated:
Essa Pharma - Next Generation of Treatments for Prostate Cancer
Developing novel therapies for the treatment of prostate cancer. EPI-7386 - a new approach to disrupting androgen receptor signaling pathway.
Network Data
This website is hosted with Google LLC, which reserves the following IP addresses for essapharma.com: 35.208.157.116. Moreover, DNS used with this website include ethan.ns.cloudflare.com, sunny.ns.cloudflare.com. Subnet identifier ranges from 35.208.0.0 to 35.247.255.255. Classless Inter-Domain Routing (CIDR) is 35.240.0.0/13, 35.208.0.0/12, 35.224.0.0/12. ARIN net type is Direct Allocation.
-
9 months ago
Last scanned
-
9 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ethan.ns.cloudflare.com
sunny.ns.cloudflare.com
Whois
OWNERSHIP
-
Created
2014-11-12
-
Expires
2023-11-12
-
Owner
On behalf of essapharma.com owner (Identity Protection Service)
-
Registar
AMAZON REGISTRAR, INC.
-
Owner Emails
Domain & Keywords
The registrar of essapharma.com is AMAZON REGISTRAR, INC. and the name expires on 2023-11-12. According to open source data, you can reach the owner at cca24845-cbac-4c47-8cb0-158e453cf753@identity-protect.org but please make sure you have a good reason for unsolicited messages. Their country of residence is United Kingdom.
- essa pharma
- essa pharma inc.
- essa pharmaceuticals
- epi-506
- essa pharma stock
Websites similar to essapharma.com
-
merck.com-
Global rank
4K
-
Daily Visitors
33.8K
-
-
schering-plough.com-
Global rank
607.1K
-
Daily Visitors
N/A
-
-
akorn.com-
Global rank
504.1K
-
Daily Visitors
534
-
-
angelinipharma.com-
Global rank
598.4K
-
Daily Visitors
534
-
-
adamaspharma.com-
Global rank
N/A
-
Daily Visitors
213
-